suzetrigine 50 MG Oral Tablet [Journavx]

Managing this medication for someone you care for? Eleplan keeps diagnoses, medications and appointments in one plan.

Start free with Eleplan

Clinical drug

suzetrigine 50 MG Oral Tablet [Journavx]

50 MG · Oral Tablet · oral

A form of suzetrigine →

suzetrigine 50 MG Oral Tablet [Journavx]. Strength, form, class, interactions & more.

suzetrigine 50 MG Oral Tablet [Journavx]

Active ingredient

Drug interactions

The label outlines several drug interactions with suzetrigine, particularly involving CYP3A inhibitors and inducers, as well as hormonal contraceptives.

  • majorstrong CYP3A inhibitors — concomitant use is contraindicated
  • moderatemoderate CYP3A inhibitors — reduce JOURNAVX dosage
  • majorstrong CYP3A inducers — avoid concomitant use
  • majormoderate CYP3A inducers — avoid concomitant use
  • moderatesensitive CYP3A substrates — dosage modification may be required
  • moderatehormonal contraceptives (other than levonorgestrel and norethindrone) — use additional nonhormonal contraceptive method
  • majorgrapefruit — avoid during treatment

Source: RxNorm + openFDA + RxClass + FAERS · 2026

Look up another medication

Powered by Eleplan

A drug lookup is just the start. Eleplan keeps the whole care plan in one place.

Medications, diagnoses, documents, appointments, and the whole care team — organized and always in sync, with Ellie, your AI care assistant, on top of it. Free to start.